Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Роль биопленок в патогенезе тяжелых инфекционных осложнений и современные возможности терапии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Гостев В.В., Сидоренко С.В. Бактериальные биопленки и инфекции. Журн. инфектологии. 2010; 2 (3): 4–15.
2. Vu B et. al. Bacterial extracellular polysaccharides involvedin biofilm formation. Molecules 2009; 14 (7): 2535–54.
3. Rakhimova E et al. Pseudomonas aeruginosa Population Biology in Chronic Obstructive Pulmonary Disease. J Of Inf Dis 2009; 200: 1928–35.
4. Lewis K. Riddle of Biofilm Resistance. J Antimicrob Chemother 2001; 45 (4): 999–1007.
5. Rasmussen K, Lewandowski Z. Microelectrode measurements of localmass transport rates in heterogeneous biofilms. Biotechnol Bioeng 1998; 59: 302–9.
6. Williams P. Quorum sensing, communication and crosskingdomsignalling in the bacterial world. Microbiology 2007; 153: 3923–38.
7. Bjarnsholt T et al. Interference of Pseudomonas aeruginosasignalling and biofilm formation for infection control. Expert Rev Mol Med 2010; 12: 121–6.
8. Roberts ME, Stewart PS. Modelling protection from antimicrobial agentsin biofilms through the formation of persister cells. Microbiology 2005; 151: 75–80.
9. Lewis K. Persister cell. Ann Rev Microbiol 2010; 64: 357–72.
10. Phillip Dellinger R et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsisand Septic Shock: 2012. Crit Care Med J 2013; 41 (2): 580–637.
11. Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004; 42: 1915–22.
12. Huang Y-F, Liu P-Y, Pan C-Y et al. Change of antimicrobial prophylaxis with anti-biofilm azithromycin for prevention of ventilator-associated pneumonia (VAP) in pediatric cardiac surgery. Am J Respir Crit Care Med 2010; 181: A3235.
13. Starner TD, Shrout JD, Parsek MR et al. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms. Antimicrob Agents Chemother 2008; 52 (1): 137–45.
14. Tateda K, Comte R, Pechere JC et al. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001; 45 (6): 1930–3.
15. Синопальников А.И., Астафьев А.В. Подходы к рациональной антимикробной терапии внебольничной пневмонии у госпитализированных больных. Cons. Med. 2013; 15 (3): 66–75.
2. Vu B et. al. Bacterial extracellular polysaccharides involvedin biofilm formation. Molecules 2009; 14 (7): 2535–54.
3. Rakhimova E et al. Pseudomonas aeruginosa Population Biology in Chronic Obstructive Pulmonary Disease. J Of Inf Dis 2009; 200: 1928–35.
4. Lewis K. Riddle of Biofilm Resistance. J Antimicrob Chemother 2001; 45 (4): 999–1007.
5. Rasmussen K, Lewandowski Z. Microelectrode measurements of localmass transport rates in heterogeneous biofilms. Biotechnol Bioeng 1998; 59: 302–9.
6. Williams P. Quorum sensing, communication and crosskingdomsignalling in the bacterial world. Microbiology 2007; 153: 3923–38.
7. Bjarnsholt T et al. Interference of Pseudomonas aeruginosasignalling and biofilm formation for infection control. Expert Rev Mol Med 2010; 12: 121–6.
8. Roberts ME, Stewart PS. Modelling protection from antimicrobial agentsin biofilms through the formation of persister cells. Microbiology 2005; 151: 75–80.
9. Lewis K. Persister cell. Ann Rev Microbiol 2010; 64: 357–72.
10. Phillip Dellinger R et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsisand Septic Shock: 2012. Crit Care Med J 2013; 41 (2): 580–637.
11. Moskowitz SM, Foster JM, Emerson J, Burns JL. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004; 42: 1915–22.
12. Huang Y-F, Liu P-Y, Pan C-Y et al. Change of antimicrobial prophylaxis with anti-biofilm azithromycin for prevention of ventilator-associated pneumonia (VAP) in pediatric cardiac surgery. Am J Respir Crit Care Med 2010; 181: A3235.
13. Starner TD, Shrout JD, Parsek MR et al. Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and diminish established biofilms. Antimicrob Agents Chemother 2008; 52 (1): 137–45.
14. Tateda K, Comte R, Pechere JC et al. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001; 45 (6): 1930–3.
15. Синопальников А.И., Астафьев А.В. Подходы к рациональной антимикробной терапии внебольничной пневмонии у госпитализированных больных. Cons. Med. 2013; 15 (3): 66–75.
Авторы
Д.А.Сычев
ГБОУ ДПО РМАПО Минздрава России
ГБОУ ДПО РМАПО Минздрава России
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.